ARCHIVES

Cooperative Group chairmen Cool, But High Priority Trials To Continue

This article is from The Cancer Letter archive.

Vol. 17 No. 03 | January 18, 1991

Download PDF Visit The Full Archive

Related Articles

Republican Contenders Slam FDA Decision In Care Of Boy With Treatable Brain Tumor.

February 4, 2000

Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million

June 21, 1974

NCI Budget Picture: New Grants Down, No New Center Awards, Many Projects Left Unfunded

December 10, 1976

Bristol-Myers, Karolinska In Collaboration For Studies.

March 31, 2000

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Cancer Prevention Fellowship Program seek applicants.

April 23, 2004